Effectiveness of nCPAP for moderate preterm infants compared to BiPAP : A Randomized, Controlled Non-Inferiority Trial.
Bi-level positive airway pressure (BiPAP) have been used in preterm infants with respiratory distress recently as an alternative to nasal continuous positive airway pressure (nCPAP) because theoretically, BiPAP is thought to be more effective compared to nCPAP. However, the results of some studies comparing nCPAP with BiPAP as the initial respiratory support were controversial according to different gestational age. The aim of this study is to compare clinical effectiveness and safety of nCPAP with BiPAP at gestational age of 30+0 to 34+6 weeks. A total 93 infants with gestational age of 30+0 to 34+6 weeks who presented respiratory distress within 24 hours after birth were randomized to the nCPAP group or the BiPAP group. The primary outcome was the incidence of treatment failure with these two non-invasive respiratory support devices. Criteria for treatment failure included any of the following: respiratory acidosis (PaCO2 > 65 mmHg with pH < 7.2), hypoxia (FiO2 > 0.4), or apnea (>2-3 episodes of apnea/hour). There was no statistically significant difference in treatment failure between the two groups (p = 0.576). The risk difference comparing treatment failure rate between nCPAP and BiPAP groups was -4.7 percentage points (95% CI: -21.5-11.9). nCPAP is not inferior to BiPAP as an initial management of respiratory distress in these premature infants. Therefore, we conclude that nCPAP can be used as an initial management for preterm infants at gestational age of between 30 and 35 weeks as a substitute for BiPAP.